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The aims of the present study were to analyze the effects of 16 weeks of different 
aerobic exercise training (ExT) programs with diet on cardiac autonomic modulation and 
hemodynamics in non-physically active and overweight/obese adults (n=249, 53.7±8.0 
years) with primary hypertension, and the possible differences among ExT programs and 
their effects on heart rate (HR), blood pressure (BP), and long-term BP variability (BPV). 
Participants were randomly assigned into an attention control (AC) group (physical 
activity recommendations) or one of three supervised ExT groups: high-volume of 
moderate-intensity continuous training, high-volume and high-intensity interval training 
(HIIT), and low volume-HIIT. 24 h ambulatory BP monitoring was used to analyze systolic 
and diastolic BP, HR and BPV. A cardiopulmonary exercise test was performed to 
determine peak oxygen uptake (VO2peak). Following intervention, resting and 
submaximal exercise (HR, SBP and DBP), along with diurnal and nocturnal SBP and DBP 
values decreased (P<0.05) in all groups with no differences between groups. When the 
ExT groups were combined, submaximal SBP (P=0.048) and DBP (P=0.004), VO2peak 
(P=0.014) and HR reserve (P=0.030) were significantly improved compared to AC. 
Intervention did not have significant effects on BPV. In the present study better 
improvements in the autonomic nervous system were seen when the aerobic ExT was 
individually designed and supervised with pari passu effects irrespective of exercise 
intensity and volume. Low volume-HIIT ExT combined with a healthy diet should be 
considered as a time efficient and safe mechanism for reducing the cardiovascular risk 




Primary hypertension (HTN) is associated with dysfunctional autonomic cardiovascular 
control (i.e. inappropriate activation of the sympathetic and reduction of the 
parasympathetic divisions), both at rest and in response to exercise (1). This dysfunction 
is mainly due to neural factors such as an enhanced pressor reflex, decreased baroreflex 
sensitivity and impaired functional sympatholysis, leading to a progressively greater 
decrease in blood flow to the working muscles during exercise (2). Hence, compared to 
normotensive individuals, those with HTN show a significant increase in heart rate (HR), 
blood pressure (BP), and BP variability (BPV, i.e., the variation of BP over time) (1). 
Current HTN guidelines highlight the risk associated with high BPV, since it represents 
an additional risk factor for cardiovascular complications (3) and is an independent 
predictor of the incidence of cardiovascular disease and mortality (4,5).  
The aforementioned abnormal cardiovascular response to exercise in those 
individuals with HTN may induce untoward events. However, a single session of aerobic 
exercise yields a reduced sympathetic outflow, which is associated with a sustained 
postexercise vasodilation in the exercising muscle, and this contributes to the fall in 
arterial BP; through adaptation this can lead to potential benefits to the individual (6). 
Likewise, a recent study assessing the acute effects of a single bout of three different 
exercise modalities (i.e., moderate-intensity continuous training, MICT; high-intensity 
interval training, HIIT, or combined training including MICT and resistance training) 
found different changes on BPV favoring the combined training (7). Regular aerobic 
exercise training (ExT), carefully designed and supervised by exercise specialists and a 
healthy diet are known to be an excellent non-pharmacological treatment against HTN-
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caused disturbances. As such ExT is strongly recommended by current European and 
American HTN guidelines (8,9). 
Whilst there is a lack of consistency between studies regarding exercise intensity 
and duration (10), previous it has been demonstrated that ExT induces positive changes 
in hemodynamic, autonomic and cardiac adaptations in individuals with HTN (11-13). 
Previously, aerobic ExT programs in individuals with HTN have included MICT and 
different volumes of HIIT of which all showed a significant reduction in BP with no 
between group differences (14). Nevertheless, to the best of our knowledge, there are 
no investigations analyzing the impact of aerobic ExT programs which differ in intensity 
and volume on resting, submaximal exercise, peak and recovery autonomic modulation, 
and long-term BPV (i.e. visit-to-visit measures spaced by months) in overweight/obese 
adults suffering from HTN. Given the clinical relevance of autonomic cardiovascular 
control, the aim of the present investigation was to study the effects of 16 weeks of 
different aerobic ExT programs with a hypocaloric diet on cardiac autonomic modulation 
and hemodynamics in overweight/obese adults with HTN. The secondary objective was 
to analyze the possible differences in HR, BP, and long-term BPV variables between 




The EXERDIET-HTA study is a multi-arm parallel, randomized, single-blind controlled 
experimental trial comparing the effects of different 16-week aerobic ExT programs 
(performed 2 days/week), in overweight/obese participants with HTN 
(www.clinicaltrials. gov, number NCT02283047). The study protocol was approved by 
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the ethics committees of the University of the Basque Country (CEISH UPV/EHU, 
279/2014, 229/2018) and clinical investigation of Araba University Hospital (2015-030). 
Medical staff were blinded to the participant randomization process. The design, 
selection criteria and procedures for the EXERDIET-HTA study have been detailed 
previously (15). 
Participants 
Non-Hispanic white EXERDIET-HTA participants (n=249, 158 men [63.5%] and 91 women 
[36.5%]) took part in the present study. All participants provided written informed 
consent before any data collection. Figure 1 presents a flow diagram of the study 
process for this sample. On the other hand, a HEALTHY sample (n=30) was recruited 
from the community and excluded if they had any chronic medical illness, were taking 
any daily prescription medications, had current medical symptoms, had abnormal 
findings on physical examination (including BP≥140/90 mmHg, or overweight ≥25 
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The measurements for the current study were taken pre (T0) and post a 16-week 
intervention period (T1). The HEALTHY sample only performed baseline measurements 
with no intervention procedures. 
Blood pressure 
Participants wore an ambulatory blood pressure monitor (ABPM) over a 24-h period 
using an oscillometric ABPM 6100 (Welch Allyn, New York City, NY, USA) device to 
evaluate BP in line with the European guidelines (5). Values of ABPM are shown as the 
mean of global (24 h), day and night hours for systolic BP (SBP) and diastolic BP (DBP). 
Blood pressure variability, expressed as coefficient of variation (CV), was calculated by 
the standard deviation (SD) of the BP values over a defined period of the 24h and by the 
day and night hour period respectively (13,16). Resting HR was assessed as the mean 
global of the 24 h measurements. 
Cardiorespiratory fitness (CRF) 
A cardiopulmonary exercise test was used to determine peak oxygen uptake (VO2peak) 
and ventilatory thresholds (VT). The cardiopulmonary exercise test was performed on 
an electronically braked Lode Excalibur Sport cycle ergometer (Groningen, The 
Netherlands). The test protocol started at 40W for HTN individuals and at 70W for the 
HEALTHY group (∼70 rpm), with gradual increments of 10W being applied every minute 
until volitional exhaustion occurred. Continuous electrocardiogram monitoring was 
conducted throughout each test. Expired gas was analyzed using a commercially 
available metabolic cart (Ergo CardMedi-soft S.S, Belgium; Ref. USM001 V1.0). 
Achievement of VO2peak criteria have previously been defined (17). Submaximal BP and 
HR were obtained at the fourth minute of the test and peak values were taken from the 
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peak at maximal effort. Ventilatory thresholds (VT1 and VT2) were assessed using 
standardized methods using the ventilatory equivalents (17). After completion of the 
test, participants remained seated on the bike for five minutes of recovery to assess 
electrocardiogram, HR and BP. Heart rate variables during the recovery period were 
calculated from the cardiopulmonary exercise test as follows: heart rate reserve (HRR), 
difference between HRpeak during exercise and pre-exercise HRrest; HRrec1, HR at one 
minute recovery; and HRrec, difference between HRpeak and HRrec1. Blood pressure 
recovery variables (SBP and DBP) were obtained at minute three of the recovery period. 
Based on VT1 and VT2, the three exercise intensity domains (i.e. R1, light to moderate, 
HR<VT1; R2, moderate to high, HR between VT1 and VT2; R3, high to severe HR>VT2 to 
HRpeak) were determined (17). 
Medication 
In the EXERDIET-HTA sample, prescribed medications were recorded and classified into 
the following groups: betablockers, angiotensin-converting enzyme inhibitors (ACEIs), 
angiotensin II receptor blockers (ARBs), calcium channel blockers, diuretics, and other 
antihypertensive drugs. Medical staff controlled and prescribed all necessary changes to 
medication before intervention. Pharmacological treatment was not changed during the 
intervention. 
Intervention 
All participants from the EXERDIET-HTA sample underwent a hypocaloric and controlled 
sodium diet (3-6 g/d) (14). Following baseline data collection, participants were 
randomly allocated to one of the four intervention groups: the attention control (AC) 
group (only received general physical activity recommendations in one face-to-face 
session, with no supervised exercise), or the three supervised ExT groups: high-volume 
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(HV) MICT, HV-HIIT, or low-volume (LV) HIIT. Each group was stratified by sex, SBP, body 
mass index (BMI) and age (14,15). 
The three ExT groups trained two non-consecutive days per week under the 
supervision of exercise specialists. All sessions started and finished with BP monitoring, 
and training intensity was dictated by individual HR responses (Polar Electro, Kempele, 
Finland) and the rate of perceived exertion (Borg’s 6–20 point scale). Each session 
included a 5–10-min warm-up and a 10-min cool-down. The core part of each training 
session consisted of a range of aerobic exercises, i.e. one day of the week on the 
treadmill, and the second one on the bike (BH Fitness equipment, Vitoria-Gasteiz, Spain). 
The HV-MICT group performed 45 min aerobic exercise (i.e. continuous steady training 
at R2), the HV- and LV-HIIT groups performed 45 and 20 minutes, respectively. The 
intensity in HIIT groups was individually tailored to each participant’s HR at moderate 
(R2) or vigorous (R3) intensities, adjusting the speed and/or incline of the treadmill or 
the power and speed on the exercise bike. Supervised exercise training protocols have 
previously been explained in detail (14,15). 
As participants were overweight/obese the combined used of stationary exercise 
bike and treadmill was used to avoid the osteoarticular impact of two weekly treadmill 
sessions.  
Statistical analysis 
Descriptive statistics were calculated for all variables. Comparison between HEALTHY vs. 
HTN groups was conducted using the Student t-test for independent samples. Analysis 
of variance was used to determine if there were significant pre-intervention between-
group differences. The comparison of frequencies in categorical variables among groups 
was performed using the chi-square test. A two sample paired t-test was used to 
9 
 
determine whether there was a significant difference in the recorded data between T0 
and T1 within each group. Analysis of covariance was used to examine the delta (∆) score 
for each group (AC, HV-MICT, HV-HIIT, LV-HIIT), adjusting for age, sex, body mass and 
the initial value of each of the dependent variables. Helmert contrasts were performed 
to analyze the difference between the three ExT groups pooled together and the AC 
group. Bonferroni correction was used to determine the significance when a significant 
main effect was found. The required sample size was determined for the primary 
outcome variable (SBP). It was identified that adequate power (0.80) to evaluate 
differences in our design consisting of four experimental groups would be achieved with 
164 people (41 each group, α=0.05, effect size f=0.27) based on the pilot study with an 
SD of 9 mmHg. Data were analyzed according to the intention-to-treat principle. 
Statistical significance was set at P<0.05. All statistical analyses were performed with  
SPSS version 24.0. 
Results 
The characteristics of the HTN population and HEALTHY group are presented in Table 1. 
At baseline, mean BMI in all HTN groups was above 30 kg/m2, which is considered 
obesity, and waist circumference was >100 cm, which is considered a cardiovascular risk 
factor (18). No significant between-group differences were found in any variable for the 
groups with HTN. 
Comparing the entire HTN sample with the HEALTHY group, significant 
differences were found in all baseline variables (P<0.001). Body mass index, waist 
circumference, rest BP, and HRrest values were significantly higher in the HTN group 
compared to the HEALTHY group. However, HRpeak and VO2peak were significantly lower 
(Table 1).  
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Table 1. Baseline characteristics for each group of participants. 
  
    HTN GROUPS  
 HEALTHY 
(N = 30) 
HTN 
(N = 259) 
P-value 
HEALTHY vs. HTN 
AC 
(N = 59) 
HV-MICT 
(N = 60) 
HV-HIIT 
(N = 61) 
LV-HIIT 
(N = 62) 
P-value 
Intergroups HTN 
Sex (men/women) 13/17 163/96 <0.001 33/26 38/22 40/21 41/21 0.642 
Age (years) 40.5±8.7 53.7±8.0 <0.001 52.9±8.5 54.2±7.2 53.1±8.6 54.4±7.2 0.650 
BMI (kg/m2) 23.1±2.7 32.1±4.2 <0.001 32.4±4.6 32.1±4.3 31.6±3.7 32.0±4.2 0.751 
Waist perimeter (cm) 75.1±8.0 103.1±11.1 <0.001 102.9±10.6 104.1±12.4 101.2±11.0 104.1±10.6 0.449 
Rest SBP (mmHg) 114.1±6.7 136.5±12.6 <0.001 138.5±14.0 135.4±11.5 134.8±11.8 137.2±13.3 0.353 
Rest DBP (mmHg) 68.3±7.2 78.2±8.4 <0.001 78.2±8.8 76.7±8.0 78.8±7.9 79.0±8.2 0.392 
HRrest (bpm) 58.2±6.9 71.2±10.1 <0.001 70.4±9.2 72.9±10.7 70.3±9.9 72.1±11.1 0.396 
HRpeak (bpm) 178.7±9.7 154.5±16.8 <0.001 150.2±17.6 154.9±16.5 156.2±15.7 158.3±15.7 0.052 
HRrec (bpm) 35.3±11.1 26.8±10.9 <0.001 26.0±8.8 27.5±11.7 27.3±12.6 26.2±10.6 0.814 
VO2peak (mL·kg-1·min-1) 48.1±9.0 22.6±5.5 <0.001 22.1±5.5 22.0±5.2 22.7±4.8 22.7±5.4 0.816 
Concomitant diseases    




Values are mean±SD, percentage (%) or number. HTN: hypertension; AC: attention control group; HV: high volume; LV: low volume; MICT: moderate-intensity continuous training group; HIIT: 
high-intensity interval training group; BMI: body mass index; SBP: systolic blood pressure; DBP: diastolic blood pressure; HRrest: resting heart rate; HRpeak: peak heart rate; HRrec: difference 
between HRpeak and HR after recovery’s first minute; VO2peak: peak oxygen uptake; DM: diabetes mellitus; ACEI: angiotensin converting enzyme inhibitors; ARB: angiotensin II receptor blockers. 
Blood pressure (BP) values show the mean BP calculated by 24-hour ambulatory blood pressure monitoring. P<0.05 
 
 Smoking (%)  4.2 9.9 18.7 9.4 0.076 
Antypertensive medication    
 Medication (%)  87.9 91.7 83.6 88.7 0.594 
 Number antihypertensive drugs  1.6±1.0 1.8±1.2 1.5±1.1 1.6±1.1 0.492 
 Beta-blockers (%)  10.5 8.3 6.6 4.8 0.678 
 ACEI (%)  43.9 38.3 42.6 27.4 0.229 
 ARB (%)  45.6 43.3 29.5 50.0 0.119 
 Calcium channel blocker (%)  7.0 20 13.1 14.5 0.242 
 Diuretic (%)  36.8 43.3 41.0 35.5 0.801 
 Other antihypertensive drugs (%)  3.9 5.3 3.3 5.8 0.617 
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Regarding pharmacological therapy, 87.1% of HTN participants were taking 
regular medication. The percentage of participants who took one, two, three, four or 
more medications was 38.7%, 29%, 13.7% and 5.6%, respectively. Regarding medication 
type, 7.3% of participants took beta-blockers, 37.7% angiotensin converting enzyme 
inhibitors, 41.7% angiotensin II receptor blockers, 13.8% calcium channel blockers, 
38.5% diuretics and 4.6% other antihypertensive drugs. With respect to other 
concomitant diseases, 6.1% had diabetes mellitus and 10.6% were smokers. No 
significant differences were found among HTN groups for any baseline variable. 
Following the 16-week intervention period, resting and submaximal HR, SBP and 
DBP decreased (P<0.05) in all groups (Table 2), except AC group´s submaximal SBP. 














AC vs. ExT 
P-value 
Intergroups F-value Effect size 
Rest  
HRrest (bpm)  
T0 70.1±9.2 72.8±10.1 69.9±10.3 72.3±11.3     
T1 66.3±8.8* 67.4±9.1* 63.6±8.3* 66.1±10.7* 0.054 0.331 1.148 0.016 
Global SBP (mmHg)  
T0 138.6±13.9 135.0±11.4 134.5±11.9 136.9±13.5     
T1 133.7±14.5* 130.2±10.4* 130.3±11.3* 130.5±11.7* 0.905 0.777 0.366 0.005 
Global DBP (mmHg)  
T0 78.5±8.1 76.2±7.9 78.5±8.0 79.1±8.3     
T1 75.5±8.9* 73.6±7.8* 74.5±7.0* 75.4±7.7* 0.661 0.700 0.475 0.007 
Submaximal 
HRsubmax (bpm)  
T0 121.6±16.8 126.8±18.5 123.7±23.0 123.2±16.8     
T1 115.3±15.5* 116.5±17.9* 110.9±13.3* 114.6±16.8* 0.109 0.239 1.418 0.019 
SBP (mmHg)  
T0 178.9±35.8 182.8±34.9 177.8±23.3 173.6±24.3     
T1 169.8±25.3 164.7±30.4* 158.5±23.1* 155.0±25.0* 0.048 0.395 0.997 0.014 
DBP (mmHg)  
T0 96.0±13.6 97.8±15.2 99.6±15.6 97.6±14.7     
T1 92.1±12.9* 90.1±15.2* 87.0±12.2* X 88.9±11.9* 0.004 0.027 3.106 0.042 
Peak  
HRpeak (bpm)  
T0 151.5±17.7 155.0±16.8 155.7±16.0 157.6±15.7     
T1 152.5±15.6 157.0±16.4 157.4±13.0 158.7±13.0 0.748 0.978 0.067 0.001 
SBP (mmHg)  
T0 218.5±25.6 214.8±27.9 207.3±27.6 209.5±26.1     
T1 216.7±21.8 210.0±28.0 205.9±26.1 208.3±23.4 0.425 0.722 0.444 0.006 
DBP (mmHg)  
T0 102.1±24.1 99.9±15.0 100.9±14.7 102.0±16.6     
T1 98.6±17.4 99.1±14.7 95.1±14.5* 99.0±17.3 0.930 0.574 0.666 0.009 
VO2peak (mL·kg-1·min-1)  
T0 22.3±5.6 22.0±5.2 22.7±4.9 22.7±5.3     
T1 22.8±8.0 24.3±8.8* 28.1±9.7*X 26.7±11.3* 0.014 0.046 2.708 0.036 
Recovery  
HRR (bpm)  
T0 80.2±20.3 81.6±16.8 85.8±16.5 85.6±17.6     
T1 79.9±27.8 92.6±28.2* 93.4±34.1 92.2±20.5* 0.030 0.274 1.304 0.017 
HRrec1 (bpm)  
T0 125.5±20.2 127.8±19.4 128.6±19.7 131.6±17.1     
T1 126.8±15.7 130.1±20.6 129.2±15.9 129.0±15.9 0.608 0.353 1.092 0.015 
HRrec (bpm)  
T0 26.3±8.3 27.0±11.2 27.2±12.7 25.9±10.6     
T1 26.2±17.3 26.5±10.7 26.8±11.7 29.3±9.3* 0.698 0.350 1.099 0.014 
SBPrec3 (mmHg)  
T0 155.4±24.7 154.3±20.1 147.0±23.6 152.7±22.4     
T1 150.5±22.1 147.1±28.1 141.3±22.1 142.3±18.7* 0.829 0.771 0.375 0.005 
DBPrec3 (mmHg)  
T0 85.7±12.8 84.3±10.6 88.7±10.7 86.1±12.7     
T1 82.6±11.9 79.4±12.4* 79.1±10.7*X 81.6±10.9* 0.141 0.039 2.833 0.039 
Mean±SD. HRR: heart rate reserve (peak HR-rest HR); HRrec1: heart rate after recovery’s first minute; HRrec: difference between HRpeak 
and HRrec1; SBP: systolic blood pressure; DBP: diastolic blood pressure; VO2peak: peak oxygen uptake; AC: attention control group; 
ExT: exercise training group; HV: high volume; LV: low volume; MICT: moderate-intensity continuous training group; HIIT: high-
intensity interval training group. *P value<0.05 from T0. XP value<0.05 from the AC. 
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 Cardiorespiratory fitness expressed as VO2peak (mL·kg-1·min-1) increased in all ExT 
groups (HV-MICT ∆= 10.5%, P=0.025; HV-HIIT ∆= 23.8%, P<0.001, and LV-HIIT ∆= 17.6%; 
P=0.005). In addition, HV-MICT and LV-HIIT showed an increase in HRR (∆= 13.5%, 
P=0.004 and ∆= 7.7%, P=0.017, respectively), and only LV-HIIT group decreased SBP after 
3 min of recovery (∆= -4.4%, P=0.001). On the other hand, DPB at 3 min of recovery was 
reduced in all ExT groups (HV-MICT ∆= -5.8%, P=0.013; HV-HIIT ∆= -10.8% and LV-HIIT 
∆= -5.2%, P<0.001) after the intervention period. Only LV-HIIT group showed an 
increased number of beats between HRpeak and the HRrec1 (∆= 13.1%, P=0.015). Following 
Bonferroni correction, there were no significant between-group differences in any 
resting variable. However, AC showed a smaller reduction compared to HV-HIIT group 
in submaximal DBP (P=0.017) mean difference 8.319, 95% confidence interval (CI) 0.968-
15.671 mmHg; VO2peak (P=0.049) mean difference -4.564, 95% (CI) -9.126-0.002 mL·kg-
1·min-1; and DBPrec3 (P=0.041) mean difference 6.498, 95% (CI) 0.166-12.830 mmHg. 
Furthermore, there were significant differences between all ExT groups as a whole and 
AC group in submaximal SBP (P=0.048), DBP (P=0.004), VO2peak (P=0.014) and HRR 
(P=0.030). 
After the 16-week intervention, diurnal and nocturnal SBP and DBP significantly 
(P<0.05) decreased in all groups (Table 3), with no between-group differences. However, 
the intervention did not have significant effects on any of the BPV variables (i.e., CV of 
BP). Taking into account all ExT groups together, a significant decrease was found in day-






To our knowledge, this is the first intervention investigating the effects of different 
volume (HV vs. LV) and intensity (MICT vs. HIIT) aerobic ExT programs on hemodynamics 
and cardiac autonomic modulation in hypertensive and overweight/obese individuals. 
The present investigation confirms that a dual treatment with aerobic ExT and diet is 
helpful to reduce resting and submaximal HR, together with global, day and night BP 
values. Further, ExT groups showed a greater improvement in CRF, HRR and submaximal 
BP compared to the AC group. Nevertheless, 16-weeks of aerobic ExT and diet 
intervention did not reduce BPV. Importantly, the lack of post-intervention difference 
between-ExT groups in most of the studied variables suggested that the most effective 
method was ExT using the LV-HIIT protocol. 
The lower VO2peak seen in HTN group compared to HEALTHY group (22.6±5.5 
mL·kg-1·min-1 vs. 48.1±9.0 mL·kg-1·min-1, Table 1) (19) at baseline may be the result of 
both reduced peak cardiac output, secondary to impaired resting, peak and reserve HR, 
or arterial-venous oxygen content difference, secondary to an impaired sympatholysis 
with high BP values (2,20). These alterations are presented as a result of sustained 
sympatho-excitation and reduced vagal activity, which explains the likely association of 
HR and HTN, facilitating further body fat gain and progression of associated co-
morbidities (20,21). Therefore, autonomic modulation through diet (caloric restriction) 
and aerobic exercise is currently the recommended approach (8). Findings from the 
current study support this as we report a decrease in resting (AC=-5.4%, HV-MICT=-7.4%, 
HV-HIIT=-9%, LV-HIIT=-8.6%) and submaximal HR (AC=-5.2%, HV-MICT=-8.1%, HV-HIIT=-
10.3%, LV-HIIT=-7.0%). Further, it was found an average net reduction of 5 mmHg in 
resting SBP and 3-4 mmHg in resting DBP, with no between-group differences. Although 
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one session of HIIT seems to promote a greater post-exercise hypotension compared to 
isocaloric MICT (22), in the present study long-term physical activity and ExT improved 
cardiovascular autonomic function by shifting the balance towards vagal dominance and 
decreased sympathetic activity, independent of FITT principle (i.e., Frequency, Intensity, 
Time, Type of exercise). Thus, the diet intervention along with hypertensive medication 
in the study population might have induced a similar effect regardless of physical activity 
program (unsupervised or supervised). Hence, it could be suggested that ExT provided 
no additional benefit to cardiovascular health than caloric restriction in lowering HR and 
BP (23). However, consistent with previous studies (12,24), the lower submaximal SBP 
and DBP, and higher VO2peak and HRR found in the supervised ExT groups (Table 2) 
highlights the additional beneficial effects of supervised ExT. Adding to that, although 
peak HR remained unchanged in the present study, the higher VO2peak and HRR together 
with a lower submaximal HR and a reduction in resting HR are independent risk factors 
for the reduction of coronary heart disease and cardiovascular disease morbidity and 
mortality (25). Further, previous studies have shown that a higher CRF is associated with 
lower SBP responses during submaximal exercise in hypertensive population, leading to 
an important reduction in the risk of left ventricular hypertrophy (26). Thus, a lower 
ambulatory and exercise BP, secondary to aerobic ExT, is driven by a reduction in 
systemic vascular resistance and is included as a behavioral intervention, since even the 
smallest reduction (1 mmHg) in SBP is associated with lower cardiovascular risk (27). The 
underlying mechanisms suggested to be responsible for the aforementioned benefits of 
ExT have previously been explored (2), i.e., a decrease of the enhanced exercise pressor 
reflex, including mechano- and metaboreflex, and an improvement of the impaired 
functional sympatholysis, leading to a greater muscle blood flow to the active muscles 
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during exercise and normal cardiovascular response. Therefore, although in the present 
study the autonomic function was non-directly assessed, the changes observed in HR 
and BP could be considered the mirror of an improved autonomic function taking into 
account that in HTN the parasympathetic impairment is not only related to the heart or 
cardiovascular system, but also to all para-sympathetically dependent functions (1). 
fig 
















Day-time SBP (mmHg) 
T0 141.9±14.0 138.0±11.6 138.4±12.1 140.3±14.0     
T1 137.1±14.4* 133.2±11.0* 133.0±11.2* 134.1±12.0* 0.589 0.921 0.163 0.002 
Day-time DBP (mmHg) 
T0 81.3±8.6 78.7±8.4 82.0±7.9 81.8±9.0     
T1 78.1±9.3* 76.2±8.5* 77.2±7.0* 78.1±8.0* 0.701 0.431 0.922 0.013 
Night-time SBP (mmHg) 
T0 127.9±17.9 123.5±13.6 121.8±14.8 122.9±15.2     
T1 121.8±18.0* 118.4±13.5* 118.5±15.2* 116.6±13.9* 0.766 0.507 0.678 0.007 
Night-time DBP (mmHg) 
T0 68.4±8.8 66.6±8.5 68.5±7.2 67.7±8.2     
T1 65.3±9.3* 62.4±7.2* 65.7±7.1* 63.3±11.2* 0.553 0.700 0.475 0.007 
CV of global SBP (%) 
T0 10.4±2.8 10.6±2.0 10.6±2.6 11.1±2.6     
T1 10.8±2.8 10.3±2.5 10.4±2.5 10.7±2.1 0.098 0.450 0.884 0.012 
CV of global DBP (%) 
T0 14.0±3.3 14.4±2.5 13.8±3.0 14.3±3.1     
T1 14.1±3.7 14.1±3.3 13.3±3.1 13.6±2.9 0.277 0.723 0.442 0.006 
CV of day-time SBP (%) 
T0 8.8±2.2 9.1±1.9 8.8±2.4 9.2±2.5     
T1 9.0±2.5 8.6±2.8 9.0±2.3 8.8±2.0 0.283 0.317 1.182 0.016 
CV of day-time DBP (%) 
T0 11.1±3.4 12.1±2.9 11.0±3.0 11.4±3.6     
T1 11.7±3.4 11.4±3.5 11.1±3.0 10.7±3.0 0.023 0.072 2.364 0.032 
CV of night-time SBP (%) 
T0 10.1±3.9 10.5±6.8 9.1±3.6 10.1±4.0     
T1 9.6±3.4 10.2±5.4 9.0±4.0 9.9±3.4 0.733 0.974 0.073 0.001 
CV of night-time DBP (%) 
T0 14.1±5.6 13.1±5.6 12.8±5.1 13.9±5.9     
T1 13.1±4.5 12.9.±5.4 12.5±4.7 13.6±4.9 0.395 0.854 0.261 0.004 
Mean±SD.  
SBP: systolic blood pressure; DBP: diastolic blood pressure; CV: coefficient of variation; AC: attention control group; ExT: exercise training 
group; HV: high volume; LV: low volume; MICT: moderate-intensity continuous training group; HIIT: high-intensity interval training group. 




An increased BPV may carry some additional risk for higher incidence and faster 
progression of cardiovascular disease (28). Previous literature has suggested that BPV is 
highly related to 24-hour mean BP (quantified as the SD of the 24-hour, day and night 
mean values) and is found to be an independent predictor of the incidence of 
cardiovascular events (4). In the present study (Table 3) all groups significantly 
decreased day- and night-time SBP and DBP. However, after the intervention visit-to-
visit long-term BPV (expressed as CV, Table 3) was not significantly changed which is 
similar to previous studies (13). Previously, it has been observed that in individuals with 
a SD of daytime SBP lower than 16 mmHg, the rate of cardiovascular mortality was 
significantly less than in those with an SD equal to or above 16 mmHg (29). In the current 
study, following the 16-week intervention, the SD was less than 16 mmHg in all ExT 
groups, but not in AC group´s nocturnal SBP. As such, it seems likely that the current 16-
week intervention decreases the development of cardiovascular risk events. Further, 
daytime DBP showed lower values in ExT groups compared to AC group, further 
suggesting positive cardiovascular benefits to all ExT groups. The exact reasons for the 
lack of effect of ExT on BPV remain elusive (13). Previous reports have highlighted that 
the level of the 24 h BP and not BPV should remain the primary BP-related risk factor to 
account for in clinical practice (30).  
All the aforementioned results and discussion confirm that ExT pari passu 
improves hemodynamics and autonomic responses in overweight/obese and 
hypertensive population, irrespective of intensity and volume. The current study adds 
further evidence to the argument that LV-HIIT (twice a week) is an efficient ExT 
alternative for this population due to: 1) time efficiency (less time to get similar results) 
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(14,31), and 2) lower stress of autonomic modulation (31). These findings are relevant 
for both practitioners and clinicians alike. 
 
Study limitations 
Despite the novelty of our results providing clear evidence for the benefits of aerobic 
exercise on hemodynamics and cardiac autonomic modulation in overweight/obese 
population with HTN, we should acknowledge a few limitations of our study. First, 
physical activity performed by participants in the AC group could not be controlled. 
Second, other BPV quantifying methods, such as the calculation of the “residual BPV” or 
the average of the absolute differences between consecutive measurements (i.e., 
“average real variability”) have been proposed by other authors (3), and the 
comparability between results obtained in by different techniques is limited. 
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What is known about topic 
• Hypertension is associated with an inappropriate activation of the sympathetic and 
reduction of the parasympathetic divisions at rest and in response to exercise. 
• Regular aerobic exercise training is an excellent non-pharmacological treatment 
against hypertension-caused disturbances. 
What this study adds 
• Supervised aerobic physical activity and healthy diet may have produced a significant 
improvement in the autonomic nervous system functioning (reducing heart rate and 
blood pressure).  
• Low volume-HIIT exercise training combined with a hypocaloric diet should be 
considered as a time efficient and safe mechanism for reducing the cardiovascular 
risk in hypertensive individuals. 
• The better improvements seen when the exercise training was individually designed 
and supervised in overweight/obese individuals with hypertension empowers the 
existing professional exercise recommendations.  
 
